A Novel Risk Scoring Tool to Predict Saphenous Vein Graft Occlusion After Cardiac Artery Bypass Graft Surgery

Yujing Cheng1, Xiaoteng Ma1, Xiaoli Liu1

  • 1Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Department of Cardiology, Clinical Center for Coronary Heart Disease, Beijing Anzhen Hospital, Beijing Institute of Heart Lung and Blood Vessel Disease, Capital Medical University, Beijing, China.

Insights

A new risk score predicts saphenous vein graft (SVG) occlusion after coronary artery bypass grafting (CABG). This tool identifies patients at risk, aiding in better outcomes for CABG surgery.

Area of Science:

  • Cardiovascular Surgery
  • Medical Informatics
  • Clinical Risk Prediction

Background:

  • Coronary artery bypass grafting (CABG) success is limited by saphenous vein graft (SVG) occlusion.
  • Identifying factors influencing SVG occlusion is crucial for improving patient prognosis.
  • A validated predictive tool for SVG occlusion is needed.

Purpose of the Study:

  • To develop and validate a predictive risk score for late SVG occlusion following CABG.
  • To identify key clinical factors associated with SVG occlusion post-CABG.

Main Methods:

  • Retrospective cohort study of 3,716 CABG patients (2,477 derivation, 1,239 validation).
  • Cox proportional hazards regression analyzed baseline clinical data for impact on graft occlusion.
  • A risk scoring tool was developed and validated using c-statistics and probability comparisons.

Main Results:

  • Late SVG occlusion occurred in 25.8% of patients.
  • Risk factors included female sex, diabetes, smoking, hyperuricemia, dyslipidemia, prior PCI, and number of SVG/lesion vessels.
  • Protective factors were on-pump surgery and use of ACEI/ARB and CCB medications.

Conclusions:

  • An 11-variable risk scoring tool for late SVG occlusion after CABG was successfully developed and validated.
  • The tool demonstrated good discrimination with a c-statistic of 0.71 in the validation cohort.
  • This easy-to-use score aids in estimating the risk of SVG occlusion, potentially improving patient management.